nodes	percent_of_prediction	percent_of_DWPC	metapath
Regorafenib—ABCG2—gout	0.406	1	CbGaD
Regorafenib—UGT1A1—Naproxen—gout	0.0769	0.165	CbGbCtD
Regorafenib—UGT1A9—Indomethacin—gout	0.0621	0.133	CbGbCtD
Regorafenib—UGT1A1—Indomethacin—gout	0.0508	0.109	CbGbCtD
Regorafenib—CYP2B6—Colchicine—gout	0.0226	0.0483	CbGbCtD
Regorafenib—CYP2C8—Naproxen—gout	0.0225	0.0482	CbGbCtD
Regorafenib—ABCG2—Hydrocortisone—gout	0.0172	0.0369	CbGbCtD
Regorafenib—CYP2C8—Colchicine—gout	0.0171	0.0366	CbGbCtD
Regorafenib—CYP2C9—Naproxen—gout	0.0157	0.0336	CbGbCtD
Regorafenib—CYP2C8—Probenecid—gout	0.0153	0.0327	CbGbCtD
Regorafenib—CYP2C19—Probenecid—gout	0.0128	0.0275	CbGbCtD
Regorafenib—CYP2C19—Indomethacin—gout	0.0125	0.0267	CbGbCtD
Regorafenib—CYP2C9—Colchicine—gout	0.0119	0.0255	CbGbCtD
Regorafenib—ABCB1—Colchicine—gout	0.0116	0.0247	CbGbCtD
Regorafenib—CYP2C9—Probenecid—gout	0.0107	0.0228	CbGbCtD
Regorafenib—CYP2C9—Indomethacin—gout	0.0104	0.0222	CbGbCtD
Regorafenib—ABCB1—Probenecid—gout	0.0104	0.0222	CbGbCtD
Regorafenib—ABCB1—Methylprednisolone—gout	0.0102	0.0219	CbGbCtD
Regorafenib—ABCB1—Indomethacin—gout	0.0101	0.0216	CbGbCtD
Regorafenib—CYP2C8—Hydrocortisone—gout	0.00918	0.0196	CbGbCtD
Regorafenib—CYP2C19—Prednisone—gout	0.00767	0.0164	CbGbCtD
Regorafenib—CYP3A4—Colchicine—gout	0.00693	0.0148	CbGbCtD
Regorafenib—ABCB1—Prednisolone—gout	0.00655	0.014	CbGbCtD
Regorafenib—ABCB1—Hydrocortisone—gout	0.00621	0.0133	CbGbCtD
Regorafenib—CYP3A4—Probenecid—gout	0.0062	0.0133	CbGbCtD
Regorafenib—ABCB1—Prednisone—gout	0.00619	0.0132	CbGbCtD
Regorafenib—CYP3A4—Methylprednisolone—gout	0.00612	0.0131	CbGbCtD
Regorafenib—CYP3A4—Prednisolone—gout	0.00393	0.0084	CbGbCtD
Regorafenib—CYP3A4—Hydrocortisone—gout	0.00372	0.00796	CbGbCtD
Regorafenib—CYP3A4—Prednisone—gout	0.00371	0.00793	CbGbCtD
Regorafenib—Sorafenib—ABCG2—gout	0.00249	1	CrCbGaD
Regorafenib—FLT1—HIF-2-alpha transcription factor network—ABCG2—gout	0.00127	0.0462	CbGpPWpGaD
Regorafenib—ABCB1—Abacavir transmembrane transport—ABCG2—gout	0.00108	0.0396	CbGpPWpGaD
Regorafenib—UGT1A1—Irinotecan Pathway—ABCG2—gout	0.00104	0.0379	CbGpPWpGaD
Regorafenib—UGT1A9—Irinotecan Pathway—ABCG2—gout	0.00104	0.0379	CbGpPWpGaD
Regorafenib—MAPK11—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—NLRP3—gout	0.000952	0.0348	CbGpPWpGaD
Regorafenib—FLT1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000944	0.0345	CbGpPWpGaD
Regorafenib—Protein urine present—Naproxen—gout	0.000909	0.00943	CcSEcCtD
Regorafenib—Anaemia—Probenecid—gout	0.000907	0.00941	CcSEcCtD
Regorafenib—Musculoskeletal stiffness—Naproxen—gout	0.000903	0.00937	CcSEcCtD
Regorafenib—Leukopenia—Probenecid—gout	0.000878	0.00911	CcSEcCtD
Regorafenib—Hyperuricaemia—Naproxen—gout	0.000873	0.00906	CcSEcCtD
Regorafenib—KDR—HIF-2-alpha transcription factor network—ABCG2—gout	0.000842	0.0308	CbGpPWpGaD
Regorafenib—Gastroenteritis—Indomethacin—gout	0.000837	0.00869	CcSEcCtD
Regorafenib—Blood uric acid increased—Naproxen—gout	0.000825	0.00856	CcSEcCtD
Regorafenib—Hyponatraemia—Indomethacin—gout	0.000745	0.00773	CcSEcCtD
Regorafenib—RAF1—Stimuli-sensing channels—SLC17A3—gout	0.000723	0.0264	CbGpPWpGaD
Regorafenib—EPHA2—NRF2 pathway—SLC2A9—gout	0.000709	0.0259	CbGpPWpGaD
Regorafenib—Aspartate aminotransferase increased—Colchicine—gout	0.000703	0.0073	CcSEcCtD
Regorafenib—ABL1—Factors involved in megakaryocyte development and platelet production—LRRC16A—gout	0.000697	0.0255	CbGpPWpGaD
Regorafenib—Decreased appetite—Probenecid—gout	0.000696	0.00722	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Colchicine—gout	0.000689	0.00715	CcSEcCtD
Regorafenib—Pain—Probenecid—gout	0.000685	0.00711	CcSEcCtD
Regorafenib—MAPK11—NOD1/2 Signaling Pathway—CASP1—gout	0.000681	0.0249	CbGpPWpGaD
Regorafenib—Hyponatraemia—Allopurinol—gout	0.000676	0.00701	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Indomethacin—gout	0.000668	0.00693	CcSEcCtD
Regorafenib—Gastroenteritis—Naproxen—gout	0.000663	0.00688	CcSEcCtD
Regorafenib—Body temperature increased—Probenecid—gout	0.000633	0.00657	CcSEcCtD
Regorafenib—TEK—Hemostasis—LRRC16A—gout	0.000632	0.0231	CbGpPWpGaD
Regorafenib—Neutropenia—Colchicine—gout	0.000631	0.00655	CcSEcCtD
Regorafenib—ABCB1—Abacavir transport and metabolism—ABCG2—gout	0.000623	0.0228	CbGpPWpGaD
Regorafenib—Hypokalaemia—Allopurinol—gout	0.000613	0.00636	CcSEcCtD
Regorafenib—Lymphopenia—Prednisone—gout	0.000611	0.00634	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Allopurinol—gout	0.000606	0.00629	CcSEcCtD
Regorafenib—Stomatitis—Colchicine—gout	0.000587	0.00609	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Indomethacin—gout	0.000567	0.00588	CcSEcCtD
Regorafenib—Stomatitis—Indomethacin—gout	0.000557	0.00578	CcSEcCtD
Regorafenib—Neutropenia—Allopurinol—gout	0.000544	0.00565	CcSEcCtD
Regorafenib—Dry skin—Naproxen—gout	0.000539	0.00559	CcSEcCtD
Regorafenib—Hypokalaemia—Naproxen—gout	0.000535	0.00555	CcSEcCtD
Regorafenib—Toxic epidermal necrolysis—Naproxen—gout	0.000529	0.00549	CcSEcCtD
Regorafenib—Haemoglobin—Indomethacin—gout	0.000516	0.00535	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Allopurinol—gout	0.000514	0.00534	CcSEcCtD
Regorafenib—Haemorrhage—Indomethacin—gout	0.000513	0.00533	CcSEcCtD
Regorafenib—Vomiting—Probenecid—gout	0.000509	0.00528	CcSEcCtD
Regorafenib—Endocrine disorder—Hydrocortisone—gout	0.000507	0.00526	CcSEcCtD
Regorafenib—Stomatitis—Allopurinol—gout	0.000506	0.00525	CcSEcCtD
Regorafenib—Dermatitis—Probenecid—gout	0.000504	0.00523	CcSEcCtD
Regorafenib—Headache—Probenecid—gout	0.000502	0.00521	CcSEcCtD
Regorafenib—Hepatobiliary disease—Allopurinol—gout	0.000491	0.00509	CcSEcCtD
Regorafenib—KIT—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000487	0.0178	CbGpPWpGaD
Regorafenib—Mediastinal disorder—Colchicine—gout	0.000487	0.00505	CcSEcCtD
Regorafenib—Hypothyroidism—Prednisone—gout	0.000487	0.00505	CcSEcCtD
Regorafenib—Erythema multiforme—Indomethacin—gout	0.000485	0.00504	CcSEcCtD
Regorafenib—Alopecia—Colchicine—gout	0.000477	0.00495	CcSEcCtD
Regorafenib—Nausea—Probenecid—gout	0.000476	0.00494	CcSEcCtD
Regorafenib—RAF1—Ion channel transport—SLC17A3—gout	0.000472	0.0172	CbGpPWpGaD
Regorafenib—Malnutrition—Colchicine—gout	0.00047	0.00488	CcSEcCtD
Regorafenib—Haemoglobin—Allopurinol—gout	0.000468	0.00486	CcSEcCtD
Regorafenib—Haemorrhage—Allopurinol—gout	0.000466	0.00483	CcSEcCtD
Regorafenib—MAPK11—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CASP1—gout	0.000465	0.017	CbGpPWpGaD
Regorafenib—PDGFRA—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000461	0.0169	CbGpPWpGaD
Regorafenib—Urinary tract disorder—Allopurinol—gout	0.00046	0.00477	CcSEcCtD
Regorafenib—Weight decreased—Naproxen—gout	0.00046	0.00477	CcSEcCtD
Regorafenib—Urethral disorder—Allopurinol—gout	0.000457	0.00474	CcSEcCtD
Regorafenib—Alopecia—Indomethacin—gout	0.000454	0.00471	CcSEcCtD
Regorafenib—Stevens-Johnson syndrome—Naproxen—gout	0.000449	0.00466	CcSEcCtD
Regorafenib—Acute coronary syndrome—Naproxen—gout	0.000447	0.00463	CcSEcCtD
Regorafenib—Myocardial infarction—Naproxen—gout	0.000444	0.00461	CcSEcCtD
Regorafenib—Stomatitis—Naproxen—gout	0.000442	0.00458	CcSEcCtD
Regorafenib—Erythema multiforme—Allopurinol—gout	0.00044	0.00457	CcSEcCtD
Regorafenib—Anaemia—Colchicine—gout	0.000435	0.00451	CcSEcCtD
Regorafenib—Cardiac disorder—Allopurinol—gout	0.000432	0.00449	CcSEcCtD
Regorafenib—Hepatobiliary disease—Naproxen—gout	0.000428	0.00445	CcSEcCtD
Regorafenib—Leukopenia—Colchicine—gout	0.000421	0.00437	CcSEcCtD
Regorafenib—PDGFRB—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000415	0.0152	CbGpPWpGaD
Regorafenib—Anaemia—Indomethacin—gout	0.000413	0.00429	CcSEcCtD
Regorafenib—Alopecia—Allopurinol—gout	0.000412	0.00427	CcSEcCtD
Regorafenib—Haemoglobin—Naproxen—gout	0.000409	0.00424	CcSEcCtD
Regorafenib—Haemorrhage—Naproxen—gout	0.000407	0.00422	CcSEcCtD
Regorafenib—Malnutrition—Allopurinol—gout	0.000406	0.00421	CcSEcCtD
Regorafenib—ABL1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000405	0.0148	CbGpPWpGaD
Regorafenib—Urinary tract disorder—Naproxen—gout	0.000402	0.00417	CcSEcCtD
Regorafenib—Leukopenia—Indomethacin—gout	0.0004	0.00415	CcSEcCtD
Regorafenib—Connective tissue disorder—Naproxen—gout	0.0004	0.00415	CcSEcCtD
Regorafenib—Urethral disorder—Naproxen—gout	0.000399	0.00414	CcSEcCtD
Regorafenib—RET—SIDS Susceptibility Pathways—IL1RN—gout	0.000394	0.0144	CbGpPWpGaD
Regorafenib—Hypertension—Indomethacin—gout	0.000386	0.004	CcSEcCtD
Regorafenib—Erythema multiforme—Naproxen—gout	0.000385	0.00399	CcSEcCtD
Regorafenib—Tremor—Allopurinol—gout	0.00038	0.00394	CcSEcCtD
Regorafenib—Cardiac disorder—Naproxen—gout	0.000377	0.00392	CcSEcCtD
Regorafenib—Endocrine disorder—Prednisone—gout	0.000377	0.00391	CcSEcCtD
Regorafenib—Nervous system disorder—Colchicine—gout	0.000376	0.00391	CcSEcCtD
Regorafenib—Thrombocytopenia—Colchicine—gout	0.000376	0.0039	CcSEcCtD
Regorafenib—Anaemia—Allopurinol—gout	0.000375	0.00389	CcSEcCtD
Regorafenib—Skin disorder—Colchicine—gout	0.000373	0.00387	CcSEcCtD
Regorafenib—Angiopathy—Naproxen—gout	0.000369	0.00383	CcSEcCtD
Regorafenib—Mediastinal disorder—Naproxen—gout	0.000367	0.0038	CcSEcCtD
Regorafenib—Leukopenia—Allopurinol—gout	0.000363	0.00377	CcSEcCtD
Regorafenib—Alopecia—Naproxen—gout	0.000359	0.00373	CcSEcCtD
Regorafenib—Thrombocytopenia—Indomethacin—gout	0.000357	0.00371	CcSEcCtD
Regorafenib—Malnutrition—Naproxen—gout	0.000354	0.00367	CcSEcCtD
Regorafenib—Hypertension—Allopurinol—gout	0.00035	0.00363	CcSEcCtD
Regorafenib—Gastroenteritis—Hydrocortisone—gout	0.000344	0.00357	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Allopurinol—gout	0.000343	0.00356	CcSEcCtD
Regorafenib—EPHA2—Direct p53 effectors—CASP1—gout	0.000337	0.0123	CbGpPWpGaD
Regorafenib—Decreased appetite—Colchicine—gout	0.000334	0.00346	CcSEcCtD
Regorafenib—Tremor—Naproxen—gout	0.000332	0.00344	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Colchicine—gout	0.000331	0.00344	CcSEcCtD
Regorafenib—Fatigue—Colchicine—gout	0.000331	0.00343	CcSEcCtD
Regorafenib—Infection—Allopurinol—gout	0.000329	0.00341	CcSEcCtD
Regorafenib—Anaemia—Naproxen—gout	0.000327	0.0034	CcSEcCtD
Regorafenib—Nervous system disorder—Allopurinol—gout	0.000325	0.00337	CcSEcCtD
Regorafenib—Thrombocytopenia—Allopurinol—gout	0.000324	0.00336	CcSEcCtD
Regorafenib—Skin disorder—Allopurinol—gout	0.000321	0.00334	CcSEcCtD
Regorafenib—Decreased appetite—Indomethacin—gout	0.000317	0.00329	CcSEcCtD
Regorafenib—Leukopenia—Naproxen—gout	0.000317	0.00329	CcSEcCtD
Regorafenib—Fatigue—Indomethacin—gout	0.000314	0.00326	CcSEcCtD
Regorafenib—Gastrointestinal pain—Colchicine—gout	0.000314	0.00326	CcSEcCtD
Regorafenib—Pain—Indomethacin—gout	0.000312	0.00324	CcSEcCtD
Regorafenib—Hypertension—Naproxen—gout	0.000306	0.00317	CcSEcCtD
Regorafenib—Abdominal pain—Colchicine—gout	0.000303	0.00315	CcSEcCtD
Regorafenib—UGT1A1—NRF2 pathway—SLC2A9—gout	0.000303	0.0111	CbGpPWpGaD
Regorafenib—UGT1A9—NRF2 pathway—SLC2A9—gout	0.000303	0.0111	CbGpPWpGaD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Naproxen—gout	0.000299	0.00311	CcSEcCtD
Regorafenib—Gastrointestinal pain—Indomethacin—gout	0.000298	0.00309	CcSEcCtD
Regorafenib—Dry mouth—Naproxen—gout	0.000295	0.00306	CcSEcCtD
Regorafenib—CYP3A4—Irinotecan Pathway—ABCG2—gout	0.000293	0.0107	CbGpPWpGaD
Regorafenib—Abdominal pain—Indomethacin—gout	0.000288	0.00299	CcSEcCtD
Regorafenib—Body temperature increased—Indomethacin—gout	0.000288	0.00299	CcSEcCtD
Regorafenib—Decreased appetite—Allopurinol—gout	0.000288	0.00299	CcSEcCtD
Regorafenib—Infection—Naproxen—gout	0.000287	0.00298	CcSEcCtD
Regorafenib—Dry skin—Prednisolone—gout	0.000286	0.00297	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Allopurinol—gout	0.000286	0.00296	CcSEcCtD
Regorafenib—Nervous system disorder—Naproxen—gout	0.000283	0.00294	CcSEcCtD
Regorafenib—Pain—Allopurinol—gout	0.000283	0.00294	CcSEcCtD
Regorafenib—Thrombocytopenia—Naproxen—gout	0.000283	0.00294	CcSEcCtD
Regorafenib—Skin disorder—Naproxen—gout	0.000281	0.00291	CcSEcCtD
Regorafenib—Dry skin—Hydrocortisone—gout	0.000279	0.0029	CcSEcCtD
Regorafenib—Hypokalaemia—Hydrocortisone—gout	0.000278	0.00288	CcSEcCtD
Regorafenib—Asthenia—Colchicine—gout	0.000275	0.00286	CcSEcCtD
Regorafenib—Gastrointestinal pain—Allopurinol—gout	0.000271	0.00281	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Hydrocortisone—gout	0.000269	0.00279	CcSEcCtD
Regorafenib—EPHX2—Metabolism—BCKDHA—gout	0.000267	0.00976	CbGpPWpGaD
Regorafenib—Diarrhoea—Colchicine—gout	0.000263	0.00273	CcSEcCtD
Regorafenib—Asthenia—Indomethacin—gout	0.000262	0.00272	CcSEcCtD
Regorafenib—Abdominal pain—Allopurinol—gout	0.000262	0.00271	CcSEcCtD
Regorafenib—Body temperature increased—Allopurinol—gout	0.000262	0.00271	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Methylprednisolone—gout	0.000253	0.00262	CcSEcCtD
Regorafenib—Decreased appetite—Naproxen—gout	0.000251	0.00261	CcSEcCtD
Regorafenib—Diarrhoea—Indomethacin—gout	0.00025	0.00259	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Naproxen—gout	0.000249	0.00259	CcSEcCtD
Regorafenib—Fatigue—Naproxen—gout	0.000249	0.00258	CcSEcCtD
Regorafenib—Pain—Naproxen—gout	0.000247	0.00256	CcSEcCtD
Regorafenib—Vomiting—Colchicine—gout	0.000244	0.00253	CcSEcCtD
Regorafenib—ABL1—Hemostasis—LRRC16A—gout	0.000244	0.00891	CbGpPWpGaD
Regorafenib—Rash—Colchicine—gout	0.000242	0.00251	CcSEcCtD
Regorafenib—Dermatitis—Colchicine—gout	0.000242	0.00251	CcSEcCtD
Regorafenib—Headache—Colchicine—gout	0.00024	0.0025	CcSEcCtD
Regorafenib—Weight decreased—Hydrocortisone—gout	0.000238	0.00247	CcSEcCtD
Regorafenib—Asthenia—Allopurinol—gout	0.000237	0.00246	CcSEcCtD
Regorafenib—Acute coronary syndrome—Prednisolone—gout	0.000237	0.00246	CcSEcCtD
Regorafenib—Gastrointestinal pain—Naproxen—gout	0.000236	0.00245	CcSEcCtD
Regorafenib—Myocardial infarction—Prednisolone—gout	0.000236	0.00245	CcSEcCtD
Regorafenib—Infestation NOS—Hydrocortisone—gout	0.000235	0.00244	CcSEcCtD
Regorafenib—Infestation—Hydrocortisone—gout	0.000235	0.00244	CcSEcCtD
Regorafenib—Vomiting—Indomethacin—gout	0.000232	0.00241	CcSEcCtD
Regorafenib—Acute coronary syndrome—Hydrocortisone—gout	0.000232	0.0024	CcSEcCtD
Regorafenib—Myocardial infarction—Hydrocortisone—gout	0.00023	0.00239	CcSEcCtD
Regorafenib—Rash—Indomethacin—gout	0.00023	0.00239	CcSEcCtD
Regorafenib—Dermatitis—Indomethacin—gout	0.00023	0.00238	CcSEcCtD
Regorafenib—Headache—Indomethacin—gout	0.000228	0.00237	CcSEcCtD
Regorafenib—Abdominal pain—Naproxen—gout	0.000228	0.00237	CcSEcCtD
Regorafenib—Body temperature increased—Naproxen—gout	0.000228	0.00237	CcSEcCtD
Regorafenib—Nausea—Colchicine—gout	0.000228	0.00237	CcSEcCtD
Regorafenib—Diarrhoea—Allopurinol—gout	0.000226	0.00235	CcSEcCtD
Regorafenib—RAF1—Leptin signaling pathway—IL1RN—gout	0.000223	0.00815	CbGpPWpGaD
Regorafenib—RAF1—Hemostasis—LRRC16A—gout	0.000223	0.00815	CbGpPWpGaD
Regorafenib—Infestation—Methylprednisolone—gout	0.000221	0.00229	CcSEcCtD
Regorafenib—Infestation NOS—Methylprednisolone—gout	0.000221	0.00229	CcSEcCtD
Regorafenib—EPHX2—Metabolism—PRPS1—gout	0.000218	0.00795	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—PRPS2—gout	0.000218	0.00795	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—HPRT1—gout	0.000218	0.00795	CbGpPWpGaD
Regorafenib—Acute coronary syndrome—Methylprednisolone—gout	0.000218	0.00226	CcSEcCtD
Regorafenib—Haemoglobin—Prednisolone—gout	0.000217	0.00225	CcSEcCtD
Regorafenib—NTRK1—MAPK Signaling Pathway—CASP1—gout	0.000217	0.00792	CbGpPWpGaD
Regorafenib—Nausea—Indomethacin—gout	0.000217	0.00225	CcSEcCtD
Regorafenib—Myocardial infarction—Methylprednisolone—gout	0.000216	0.00225	CcSEcCtD
Regorafenib—Haemorrhage—Prednisolone—gout	0.000216	0.00224	CcSEcCtD
Regorafenib—Haemoglobin—Hydrocortisone—gout	0.000212	0.0022	CcSEcCtD
Regorafenib—Haemorrhage—Hydrocortisone—gout	0.000211	0.00219	CcSEcCtD
Regorafenib—Vomiting—Allopurinol—gout	0.00021	0.00218	CcSEcCtD
Regorafenib—Rash—Allopurinol—gout	0.000209	0.00217	CcSEcCtD
Regorafenib—Dermatitis—Allopurinol—gout	0.000208	0.00216	CcSEcCtD
Regorafenib—Dry skin—Prednisone—gout	0.000208	0.00216	CcSEcCtD
Regorafenib—Headache—Allopurinol—gout	0.000207	0.00215	CcSEcCtD
Regorafenib—Asthenia—Naproxen—gout	0.000207	0.00215	CcSEcCtD
Regorafenib—Connective tissue disorder—Hydrocortisone—gout	0.000207	0.00215	CcSEcCtD
Regorafenib—Hypokalaemia—Prednisone—gout	0.000206	0.00214	CcSEcCtD
Regorafenib—Alanine aminotransferase increased—Prednisone—gout	0.0002	0.00208	CcSEcCtD
Regorafenib—Haemoglobin—Methylprednisolone—gout	0.000199	0.00207	CcSEcCtD
Regorafenib—Haemorrhage—Methylprednisolone—gout	0.000198	0.00206	CcSEcCtD
Regorafenib—Diarrhoea—Naproxen—gout	0.000198	0.00205	CcSEcCtD
Regorafenib—Nausea—Allopurinol—gout	0.000197	0.00204	CcSEcCtD
Regorafenib—Connective tissue disorder—Methylprednisolone—gout	0.000195	0.00202	CcSEcCtD
Regorafenib—Cardiac disorder—Methylprednisolone—gout	0.000184	0.00191	CcSEcCtD
Regorafenib—Vomiting—Naproxen—gout	0.000184	0.00191	CcSEcCtD
Regorafenib—Malnutrition—Hydrocortisone—gout	0.000184	0.00191	CcSEcCtD
Regorafenib—Neutropenia—Prednisone—gout	0.000183	0.0019	CcSEcCtD
Regorafenib—Rash—Naproxen—gout	0.000182	0.00189	CcSEcCtD
Regorafenib—Dermatitis—Naproxen—gout	0.000182	0.00189	CcSEcCtD
Regorafenib—Headache—Naproxen—gout	0.000181	0.00188	CcSEcCtD
Regorafenib—Angiopathy—Methylprednisolone—gout	0.00018	0.00187	CcSEcCtD
Regorafenib—Mediastinal disorder—Methylprednisolone—gout	0.000179	0.00185	CcSEcCtD
Regorafenib—Weight decreased—Prednisone—gout	0.000177	0.00184	CcSEcCtD
Regorafenib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—ABCG2—gout	0.000175	0.00638	CbGpPWpGaD
Regorafenib—BRAF—MAPK Signaling Pathway—CASP1—gout	0.000175	0.00638	CbGpPWpGaD
Regorafenib—Malnutrition—Methylprednisolone—gout	0.000173	0.00179	CcSEcCtD
Regorafenib—Acute coronary syndrome—Prednisone—gout	0.000172	0.00179	CcSEcCtD
Regorafenib—RAF1—Signaling by Interleukins—CASP1—gout	0.000172	0.00628	CbGpPWpGaD
Regorafenib—Nausea—Naproxen—gout	0.000172	0.00178	CcSEcCtD
Regorafenib—Myocardial infarction—Prednisone—gout	0.000171	0.00178	CcSEcCtD
Regorafenib—RAF1—Signaling by Interleukins—IL1RN—gout	0.000167	0.00609	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC17A3—gout	0.000164	0.006	CbGpPWpGaD
Regorafenib—Hypertension—Prednisolone—gout	0.000162	0.00168	CcSEcCtD
Regorafenib—Hypertension—Hydrocortisone—gout	0.000159	0.00164	CcSEcCtD
Regorafenib—Haemoglobin—Prednisone—gout	0.000158	0.00164	CcSEcCtD
Regorafenib—Haemorrhage—Prednisone—gout	0.000157	0.00163	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Hydrocortisone—gout	0.000155	0.00161	CcSEcCtD
Regorafenib—Connective tissue disorder—Prednisone—gout	0.000154	0.0016	CcSEcCtD
Regorafenib—MAPK11—Glucocorticoid receptor regulatory network—POMC—gout	0.000153	0.0056	CbGpPWpGaD
Regorafenib—FGFR1—MAPK Signaling Pathway—CASP1—gout	0.000151	0.00551	CbGpPWpGaD
Regorafenib—Hypertension—Methylprednisolone—gout	0.000149	0.00155	CcSEcCtD
Regorafenib—Infection—Hydrocortisone—gout	0.000149	0.00154	CcSEcCtD
Regorafenib—Nervous system disorder—Hydrocortisone—gout	0.000147	0.00152	CcSEcCtD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—gout	0.000146	0.00151	CcSEcCtD
Regorafenib—Skin disorder—Hydrocortisone—gout	0.000146	0.00151	CcSEcCtD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC17A3—gout	0.000143	0.00523	CbGpPWpGaD
Regorafenib—Angiopathy—Prednisone—gout	0.000142	0.00148	CcSEcCtD
Regorafenib—Infection—Methylprednisolone—gout	0.00014	0.00145	CcSEcCtD
Regorafenib—Alopecia—Prednisone—gout	0.000139	0.00144	CcSEcCtD
Regorafenib—BRAF—Corticotropin-releasing hormone—POMC—gout	0.000138	0.00506	CbGpPWpGaD
Regorafenib—Nervous system disorder—Methylprednisolone—gout	0.000138	0.00143	CcSEcCtD
Regorafenib—ABCB1—HIF-1-alpha transcription factor network—ABCG2—gout	0.000138	0.00503	CbGpPWpGaD
Regorafenib—Skin disorder—Methylprednisolone—gout	0.000137	0.00142	CcSEcCtD
Regorafenib—Malnutrition—Prednisone—gout	0.000137	0.00142	CcSEcCtD
Regorafenib—PDGFRB—MAPK Signaling Pathway—CASP1—gout	0.000136	0.00495	CbGpPWpGaD
Regorafenib—MAPK11—Innate Immune System—NLRP3—gout	0.000134	0.00491	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC17A1—gout	0.000134	0.00489	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC22A11—gout	0.000134	0.00489	CbGpPWpGaD
Regorafenib—Pain—Prednisolone—gout	0.000131	0.00136	CcSEcCtD
Regorafenib—Decreased appetite—Hydrocortisone—gout	0.00013	0.00135	CcSEcCtD
Regorafenib—Gastrointestinal disorder—Hydrocortisone—gout	0.000129	0.00134	CcSEcCtD
Regorafenib—Fatigue—Hydrocortisone—gout	0.000129	0.00134	CcSEcCtD
Regorafenib—Pain—Hydrocortisone—gout	0.000128	0.00133	CcSEcCtD
Regorafenib—Anaemia—Prednisone—gout	0.000126	0.00131	CcSEcCtD
Regorafenib—FGFR2—Innate Immune System—NLRP3—gout	0.000123	0.00451	CbGpPWpGaD
Regorafenib—Gastrointestinal pain—Hydrocortisone—gout	0.000123	0.00127	CcSEcCtD
Regorafenib—Fatigue—Methylprednisolone—gout	0.000121	0.00126	CcSEcCtD
Regorafenib—KIT—Innate Immune System—NLRP3—gout	0.000121	0.00443	CbGpPWpGaD
Regorafenib—RAF1—MAPK Signaling Pathway—CASP1—gout	0.000121	0.00441	CbGpPWpGaD
Regorafenib—Abdominal pain—Hydrocortisone—gout	0.000118	0.00123	CcSEcCtD
Regorafenib—Body temperature increased—Hydrocortisone—gout	0.000118	0.00123	CcSEcCtD
Regorafenib—Hypertension—Prednisone—gout	0.000118	0.00122	CcSEcCtD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC22A11—gout	0.000117	0.00426	CbGpPWpGaD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC17A1—gout	0.000117	0.00426	CbGpPWpGaD
Regorafenib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—gout	0.000116	0.0012	CcSEcCtD
Regorafenib—Gastrointestinal pain—Methylprednisolone—gout	0.000115	0.00119	CcSEcCtD
Regorafenib—FGFR1—Innate Immune System—NLRP3—gout	0.000115	0.0042	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—NLRP3—gout	0.000115	0.00419	CbGpPWpGaD
Regorafenib—Abdominal pain—Methylprednisolone—gout	0.000111	0.00115	CcSEcCtD
Regorafenib—Infection—Prednisone—gout	0.000111	0.00115	CcSEcCtD
Regorafenib—Nervous system disorder—Prednisone—gout	0.000109	0.00113	CcSEcCtD
Regorafenib—Skin disorder—Prednisone—gout	0.000108	0.00112	CcSEcCtD
Regorafenib—BRAF—Disease—PRPS2—gout	0.000108	0.00395	CbGpPWpGaD
Regorafenib—BRAF—Disease—PRPS1—gout	0.000108	0.00395	CbGpPWpGaD
Regorafenib—Asthenia—Hydrocortisone—gout	0.000108	0.00112	CcSEcCtD
Regorafenib—PDGFRB—Innate Immune System—NLRP3—gout	0.000103	0.00378	CbGpPWpGaD
Regorafenib—Diarrhoea—Hydrocortisone—gout	0.000103	0.00106	CcSEcCtD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC22A12—gout	0.000101	0.0037	CbGpPWpGaD
Regorafenib—Asthenia—Methylprednisolone—gout	0.000101	0.00105	CcSEcCtD
Regorafenib—ABL1—Innate Immune System—NLRP3—gout	0.000101	0.00368	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PRPS2—gout	0.0001	0.00366	CbGpPWpGaD
Regorafenib—FGFR2—Disease—PRPS1—gout	0.0001	0.00366	CbGpPWpGaD
Regorafenib—KIT—Disease—PRPS1—gout	9.84e-05	0.0036	CbGpPWpGaD
Regorafenib—KIT—Disease—PRPS2—gout	9.84e-05	0.0036	CbGpPWpGaD
Regorafenib—Decreased appetite—Prednisone—gout	9.69e-05	0.00101	CcSEcCtD
Regorafenib—Rash—Prednisolone—gout	9.68e-05	0.001	CcSEcCtD
Regorafenib—Dermatitis—Prednisolone—gout	9.67e-05	0.001	CcSEcCtD
Regorafenib—Diarrhoea—Methylprednisolone—gout	9.63e-05	0.001	CcSEcCtD
Regorafenib—Fatigue—Prednisone—gout	9.61e-05	0.000997	CcSEcCtD
Regorafenib—Headache—Prednisolone—gout	9.61e-05	0.000997	CcSEcCtD
Regorafenib—RAF1—Corticotropin-releasing hormone—POMC—gout	9.58e-05	0.0035	CbGpPWpGaD
Regorafenib—Vomiting—Hydrocortisone—gout	9.53e-05	0.000989	CcSEcCtD
Regorafenib—Rash—Hydrocortisone—gout	9.45e-05	0.00098	CcSEcCtD
Regorafenib—Dermatitis—Hydrocortisone—gout	9.44e-05	0.00098	CcSEcCtD
Regorafenib—RAF1—Transmembrane transport of small molecules—SLC2A9—gout	9.43e-05	0.00344	CbGpPWpGaD
Regorafenib—Headache—Hydrocortisone—gout	9.39e-05	0.000974	CcSEcCtD
Regorafenib—FGFR1—Disease—PRPS2—gout	9.34e-05	0.00341	CbGpPWpGaD
Regorafenib—FGFR1—Disease—PRPS1—gout	9.34e-05	0.00341	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PRPS1—gout	9.32e-05	0.0034	CbGpPWpGaD
Regorafenib—PDGFRA—Disease—PRPS2—gout	9.32e-05	0.0034	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—NLRP3—gout	9.22e-05	0.00337	CbGpPWpGaD
Regorafenib—Gastrointestinal pain—Prednisone—gout	9.12e-05	0.000946	CcSEcCtD
Regorafenib—Nausea—Prednisolone—gout	9.11e-05	0.000946	CcSEcCtD
Regorafenib—Vomiting—Methylprednisolone—gout	8.95e-05	0.000929	CcSEcCtD
Regorafenib—Nausea—Hydrocortisone—gout	8.9e-05	0.000924	CcSEcCtD
Regorafenib—Rash—Methylprednisolone—gout	8.88e-05	0.000921	CcSEcCtD
Regorafenib—Dermatitis—Methylprednisolone—gout	8.87e-05	0.00092	CcSEcCtD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC22A12—gout	8.84e-05	0.00323	CbGpPWpGaD
Regorafenib—Headache—Methylprednisolone—gout	8.82e-05	0.000915	CcSEcCtD
Regorafenib—Body temperature increased—Prednisone—gout	8.81e-05	0.000915	CcSEcCtD
Regorafenib—Abdominal pain—Prednisone—gout	8.81e-05	0.000915	CcSEcCtD
Regorafenib—CYP2B6—Cytochrome P450 - arranged by substrate type—POMC—gout	8.62e-05	0.00315	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PRPS1—gout	8.39e-05	0.00307	CbGpPWpGaD
Regorafenib—PDGFRB—Disease—PRPS2—gout	8.39e-05	0.00307	CbGpPWpGaD
Regorafenib—Nausea—Methylprednisolone—gout	8.36e-05	0.000868	CcSEcCtD
Regorafenib—ABCG2—Transmembrane transport of small molecules—SLC2A9—gout	8.22e-05	0.003	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—ABCG2—gout	8.06e-05	0.00294	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—CASP1—gout	8.03e-05	0.00293	CbGpPWpGaD
Regorafenib—Asthenia—Prednisone—gout	8e-05	0.00083	CcSEcCtD
Regorafenib—UGT1A1—Metabolism—BCKDHA—gout	7.9e-05	0.00289	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—BCKDHA—gout	7.9e-05	0.00289	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—NLRP3—gout	7.83e-05	0.00286	CbGpPWpGaD
Regorafenib—RAF1—Cytokine Signaling in Immune system—IL1RN—gout	7.77e-05	0.00284	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism of lipids and lipoproteins—POMC—gout	7.75e-05	0.00283	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC17A3—gout	7.74e-05	0.00283	CbGpPWpGaD
Regorafenib—Diarrhoea—Prednisone—gout	7.63e-05	0.000792	CcSEcCtD
Regorafenib—RAF1—Disease—PRPS2—gout	7.48e-05	0.00273	CbGpPWpGaD
Regorafenib—RAF1—Disease—PRPS1—gout	7.48e-05	0.00273	CbGpPWpGaD
Regorafenib—CYP2C8—Cytochrome P450 - arranged by substrate type—POMC—gout	7.3e-05	0.00267	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—NLRP3—gout	7.19e-05	0.00263	CbGpPWpGaD
Regorafenib—Vomiting—Prednisone—gout	7.09e-05	0.000736	CcSEcCtD
Regorafenib—KIT—Immune System—NLRP3—gout	7.06e-05	0.00258	CbGpPWpGaD
Regorafenib—Rash—Prednisone—gout	7.03e-05	0.000729	CcSEcCtD
Regorafenib—Dermatitis—Prednisone—gout	7.02e-05	0.000729	CcSEcCtD
Regorafenib—CYP2B6—Phase 1 - Functionalization of compounds—POMC—gout	6.99e-05	0.00255	CbGpPWpGaD
Regorafenib—Headache—Prednisone—gout	6.99e-05	0.000725	CcSEcCtD
Regorafenib—ABCG2—Metabolism—BCKDHA—gout	6.7e-05	0.00245	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—NLRP3—gout	6.7e-05	0.00245	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—NLRP3—gout	6.69e-05	0.00244	CbGpPWpGaD
Regorafenib—Nausea—Prednisone—gout	6.62e-05	0.000687	CcSEcCtD
Regorafenib—MAPK11—Innate Immune System—CASP1—gout	6.57e-05	0.0024	CbGpPWpGaD
Regorafenib—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—gout	6.52e-05	0.00238	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PRPS1—gout	6.44e-05	0.00235	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—HPRT1—gout	6.44e-05	0.00235	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—PRPS2—gout	6.44e-05	0.00235	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PRPS1—gout	6.44e-05	0.00235	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—PRPS2—gout	6.44e-05	0.00235	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—HPRT1—gout	6.44e-05	0.00235	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC17A1—gout	6.31e-05	0.00231	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC22A11—gout	6.31e-05	0.00231	CbGpPWpGaD
Regorafenib—FGFR2—Innate Immune System—CASP1—gout	6.03e-05	0.0022	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—NLRP3—gout	6.02e-05	0.0022	CbGpPWpGaD
Regorafenib—UGT1A1—Biological oxidations—POMC—gout	5.97e-05	0.00218	CbGpPWpGaD
Regorafenib—UGT1A9—Biological oxidations—POMC—gout	5.97e-05	0.00218	CbGpPWpGaD
Regorafenib—CYP2C9—Cytochrome P450 - arranged by substrate type—POMC—gout	5.94e-05	0.00217	CbGpPWpGaD
Regorafenib—KIT—Innate Immune System—CASP1—gout	5.92e-05	0.00216	CbGpPWpGaD
Regorafenib—CYP2C8—Phase 1 - Functionalization of compounds—POMC—gout	5.92e-05	0.00216	CbGpPWpGaD
Regorafenib—ABL1—Immune System—NLRP3—gout	5.87e-05	0.00214	CbGpPWpGaD
Regorafenib—FGFR1—Innate Immune System—CASP1—gout	5.62e-05	0.00205	CbGpPWpGaD
Regorafenib—PDGFRA—Innate Immune System—CASP1—gout	5.61e-05	0.00205	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PRPS1—gout	5.47e-05	0.002	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—HPRT1—gout	5.47e-05	0.002	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—PRPS2—gout	5.47e-05	0.002	CbGpPWpGaD
Regorafenib—RAF1—Immune System—NLRP3—gout	5.37e-05	0.00196	CbGpPWpGaD
Regorafenib—CYP2C19—Phase 1 - Functionalization of compounds—POMC—gout	5.28e-05	0.00193	CbGpPWpGaD
Regorafenib—PDGFRB—Innate Immune System—CASP1—gout	5.05e-05	0.00185	CbGpPWpGaD
Regorafenib—RAF1—Transmembrane transport of small molecules—ABCG2—gout	4.95e-05	0.00181	CbGpPWpGaD
Regorafenib—ABL1—Innate Immune System—CASP1—gout	4.92e-05	0.0018	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—BCKDHA—gout	4.91e-05	0.0018	CbGpPWpGaD
Regorafenib—CYP2C9—Phase 1 - Functionalization of compounds—POMC—gout	4.82e-05	0.00176	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC22A12—gout	4.78e-05	0.00175	CbGpPWpGaD
Regorafenib—RAF1—Innate Immune System—CASP1—gout	4.5e-05	0.00164	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—SLC2A9—gout	4.45e-05	0.00162	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—BCKDHA—gout	4.16e-05	0.00152	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—HPRT1—gout	4.01e-05	0.00146	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PRPS2—gout	4.01e-05	0.00146	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—PRPS1—gout	4.01e-05	0.00146	CbGpPWpGaD
Regorafenib—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—gout	3.92e-05	0.00143	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—CASP1—gout	3.83e-05	0.0014	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—BCKDHA—gout	3.71e-05	0.00136	CbGpPWpGaD
Regorafenib—CYP2B6—Biological oxidations—POMC—gout	3.71e-05	0.00136	CbGpPWpGaD
Regorafenib—MAPK11—Immune System—IL1RN—gout	3.7e-05	0.00135	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—BCKDHA—gout	3.62e-05	0.00132	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—CASP1—gout	3.51e-05	0.00128	CbGpPWpGaD
Regorafenib—EPHX2—Metabolism—POMC—gout	3.45e-05	0.00126	CbGpPWpGaD
Regorafenib—KIT—Immune System—CASP1—gout	3.45e-05	0.00126	CbGpPWpGaD
Regorafenib—FGFR2—Immune System—IL1RN—gout	3.4e-05	0.00124	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PRPS1—gout	3.39e-05	0.00124	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—PRPS2—gout	3.39e-05	0.00124	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—HPRT1—gout	3.39e-05	0.00124	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—BCKDHA—gout	3.39e-05	0.00124	CbGpPWpGaD
Regorafenib—KIT—Immune System—IL1RN—gout	3.34e-05	0.00122	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—CASP1—gout	3.27e-05	0.0012	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—CASP1—gout	3.26e-05	0.00119	CbGpPWpGaD
Regorafenib—CYP3A4—Phase 1 - Functionalization of compounds—POMC—gout	3.18e-05	0.00116	CbGpPWpGaD
Regorafenib—FGFR1—Immune System—IL1RN—gout	3.17e-05	0.00116	CbGpPWpGaD
Regorafenib—PDGFRA—Immune System—IL1RN—gout	3.16e-05	0.00116	CbGpPWpGaD
Regorafenib—CYP2C8—Biological oxidations—POMC—gout	3.14e-05	0.00115	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PRPS1—gout	3.03e-05	0.00111	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—PRPS2—gout	3.03e-05	0.00111	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—HPRT1—gout	3.03e-05	0.00111	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PRPS1—gout	2.96e-05	0.00108	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—HPRT1—gout	2.96e-05	0.00108	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—PRPS2—gout	2.96e-05	0.00108	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—CASP1—gout	2.94e-05	0.00107	CbGpPWpGaD
Regorafenib—ABL1—Immune System—CASP1—gout	2.87e-05	0.00105	CbGpPWpGaD
Regorafenib—PDGFRB—Immune System—IL1RN—gout	2.85e-05	0.00104	CbGpPWpGaD
Regorafenib—FLT4—Signaling Pathways—POMC—gout	2.84e-05	0.00104	CbGpPWpGaD
Regorafenib—CYP2C19—Biological oxidations—POMC—gout	2.81e-05	0.00103	CbGpPWpGaD
Regorafenib—ABL1—Immune System—IL1RN—gout	2.78e-05	0.00101	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PRPS2—gout	2.76e-05	0.00101	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—HPRT1—gout	2.76e-05	0.00101	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—PRPS1—gout	2.76e-05	0.00101	CbGpPWpGaD
Regorafenib—RAF1—Immune System—CASP1—gout	2.62e-05	0.000958	CbGpPWpGaD
Regorafenib—CYP2C9—Biological oxidations—POMC—gout	2.56e-05	0.000935	CbGpPWpGaD
Regorafenib—RAF1—Immune System—IL1RN—gout	2.54e-05	0.000928	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—ABCG2—gout	2.38e-05	0.000871	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—ABCG2—gout	2.38e-05	0.000871	CbGpPWpGaD
Regorafenib—ABCB1—Transmembrane transport of small molecules—ABCG2—gout	2.34e-05	0.000853	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism of lipids and lipoproteins—POMC—gout	2.29e-05	0.000838	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—BCKDHA—gout	2.23e-05	0.000816	CbGpPWpGaD
Regorafenib—FLT1—Signaling Pathways—POMC—gout	2.12e-05	0.000774	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PRPS1—gout	1.82e-05	0.000665	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—HPRT1—gout	1.82e-05	0.000665	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—PRPS2—gout	1.82e-05	0.000665	CbGpPWpGaD
Regorafenib—CYP3A4—Biological oxidations—POMC—gout	1.69e-05	0.000616	CbGpPWpGaD
Regorafenib—NTRK1—Signaling Pathways—POMC—gout	1.49e-05	0.000545	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—ABCG2—gout	1.48e-05	0.000542	CbGpPWpGaD
Regorafenib—KDR—Signaling Pathways—POMC—gout	1.41e-05	0.000515	CbGpPWpGaD
Regorafenib—RAF1—Signaling by GPCR—POMC—gout	1.41e-05	0.000514	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—ABCG2—gout	1.26e-05	0.000459	CbGpPWpGaD
Regorafenib—MAPK11—Signaling Pathways—POMC—gout	1.21e-05	0.000443	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism of lipids and lipoproteins—POMC—gout	1.21e-05	0.000441	CbGpPWpGaD
Regorafenib—BRAF—Signaling Pathways—POMC—gout	1.2e-05	0.000439	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—ABCG2—gout	1.12e-05	0.000409	CbGpPWpGaD
Regorafenib—FGFR2—Signaling Pathways—POMC—gout	1.11e-05	0.000406	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—ABCG2—gout	1.09e-05	0.0004	CbGpPWpGaD
Regorafenib—KIT—Signaling Pathways—POMC—gout	1.09e-05	0.000399	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism of lipids and lipoproteins—POMC—gout	1.08e-05	0.000394	CbGpPWpGaD
Regorafenib—FGFR1—Signaling Pathways—POMC—gout	1.04e-05	0.000379	CbGpPWpGaD
Regorafenib—PDGFRA—Signaling Pathways—POMC—gout	1.03e-05	0.000378	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—ABCG2—gout	1.02e-05	0.000373	CbGpPWpGaD
Regorafenib—UGT1A1—Metabolism—POMC—gout	1.02e-05	0.000373	CbGpPWpGaD
Regorafenib—UGT1A9—Metabolism—POMC—gout	1.02e-05	0.000373	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism of lipids and lipoproteins—POMC—gout	9.82e-06	0.000359	CbGpPWpGaD
Regorafenib—PDGFRB—Signaling Pathways—POMC—gout	9.32e-06	0.00034	CbGpPWpGaD
Regorafenib—ABCG2—Metabolism—POMC—gout	8.66e-06	0.000317	CbGpPWpGaD
Regorafenib—RAF1—Signaling Pathways—POMC—gout	8.3e-06	0.000303	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—ABCG2—gout	6.74e-06	0.000246	CbGpPWpGaD
Regorafenib—CYP2B6—Metabolism—POMC—gout	6.35e-06	0.000232	CbGpPWpGaD
Regorafenib—CYP2C8—Metabolism—POMC—gout	5.38e-06	0.000196	CbGpPWpGaD
Regorafenib—CYP2C19—Metabolism—POMC—gout	4.8e-06	0.000175	CbGpPWpGaD
Regorafenib—ABCB1—Metabolism—POMC—gout	4.68e-06	0.000171	CbGpPWpGaD
Regorafenib—CYP2C9—Metabolism—POMC—gout	4.38e-06	0.00016	CbGpPWpGaD
Regorafenib—CYP3A4—Metabolism—POMC—gout	2.89e-06	0.000105	CbGpPWpGaD
